Skip to main content
PBLS logo

PBLS · Parabilis Medicines, Inc.

Track PBLS — free
$40.42 -0.33 (-0.81%) At close · Sep 4
Market Cap
$4.99B
Shares
123.53M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Craig Tendler Appointed 2026-08-25
Key facts CIK 1657677 CUSIP 698955101 13F (30d) 62 filings 62 filers Visit website Investor relations